VEGFA and angiosarcoma: Notably, a study in canine hemangiosarcoma demonstrated a reduction in Vascular Endothelial Growth Factor (VEGF) expression in metastases of thalidomide-treated dogs [63], confirming the activation of anti-angiogenic mechanisms.